Which ETFs own 009420.KS?
Hanall Biopharma Co., Ltd. · Healthcare · Medical - Pharmaceuticals · KR — 10 ETFs hold it, worth $34.3M across 895.39K shares.
Holdings as of Oct 11, 2026 · portfolio reporting dates from the data provider; not live positions.
| # | ETF | Weight | Shares | Value | ETF AUM | Category | Today | |
|---|---|---|---|---|---|---|---|---|
| 1 | EEMS iShares MSCI Emerging Markets Small-Cap… | 0.06% | 7.51K | $246.9K | $390.0M | Emerging Markets | -0.57% | |
| 2 | SCHC Schwab International Small-Cap Equity… | 0.04% | 60.09K | $2.0M | $5.53B | Developed Markets | -0.77% | |
| 3 | VSS Vanguard FTSE All-World ex-US Small-Cap… | 0.03% | 117.81K | $5.2M | $14.50B | Developed Markets | -0.53% | |
| 4 | TLTE Northern Trust Morningstar Emerging… | 0.01% | 1.13K | $36.9K | $353.1M | Emerging Markets | -0.51% | |
| 5 | VPL Vanguard FTSE Pacific ETF | 0.01% | 32.13K | $1.4M | $13.80B | Developed Markets | -1.19% | |
| 6 | IEMG iShares Core MSCI Emerging Markets ETF | 0.01% | 372.68K | $12.3M | $160.25B | Emerging Markets | -0.88% | |
| 7 | DFSE Dimensional Emerging Markets… | 0.00% | 855 | $28.1K | $642.7M | Emerging Markets | -0.46% | |
| 8 | VEA Vanguard FTSE Developed Markets ETF | 0.00% | 288.38K | $12.6M | $323.80B | Developed Markets | -0.55% | |
| 9 | VSGX Vanguard ESG International Stock ETF | 0.00% | 5.71K | $249.9K | $6.80B | Developed Markets | -0.57% | |
| 10 | DFAE Dimensional - Emerging Core Equity… | 0.00% | 9.10K | $299.1K | $10.11B | Emerging Markets | -0.77% |
Coverage reflects the ETF portfolios loaded in our database; very small funds may not be swept yet. Market data delayed approximately 15–20 minutes unless otherwise indicated.